Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.
about
Complement regulation of T-cell alloimmunityComplement regulation of T cell immunityEffects of complement activation on allograft injuryEffector mechanisms of rejectionMolecules Great and Small: The Complement System.Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injuryTargeting complement component 5a promotes vascular integrity and limits airway remodelingEffects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154.Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.Complement as a multifaceted modulator of kidney transplant injury.Complement in Kidney TransplantationEarly Terminal Complement Blockade and C6 Deficiency Are Protective in Enterohemorrhagic Escherichia coli-Infected Mice.Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response.Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.
P2860
Q26823956-18FA4C66-6CE7-4941-BA85-0676A26148F0Q26827470-A2803B8D-53FE-4825-93B7-5F45413E7727Q26995453-B20FA68D-C148-4AF2-9CB7-EE57719699CBQ27027082-7906827A-535C-4E85-8225-EF842F742237Q33419651-239B285A-9CCD-491A-B929-E26B60AA56BAQ33422493-81DFE796-E3DA-46DD-A63E-F54803A34E6CQ33852943-C42F08E5-718C-4E1F-B8E5-E79DD5D101E1Q35246399-F59563E4-621D-4B05-818A-B0D423DF76D4Q36762599-F995055F-F21A-4745-8D72-466758F4B6D5Q37423395-C3157048-9992-4F4B-9704-C92AF4AA2929Q38187176-E5FD2C05-5A2A-41E3-95FC-CA04FEFBC32DQ38217273-032CFB51-7047-4A45-8772-9D0B5FDF9D9FQ39371134-33FD830B-E448-4A00-B666-E183D3955C34Q40612027-812133D0-ED0B-40D2-9DD1-ED8A2D5A74ADQ44911053-3A6FBED3-BC34-425F-AD95-6F8EFCCDD439Q48146117-D9B975BD-506D-46E8-94D9-CEB32D24E180Q50699634-DBCB0B76-6C64-438D-8DDB-3CBD6D44893A
P2860
Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-complement component C5 m ...... ac allograft survival in mice.
@ast
Anti-complement component C5 m ...... ac allograft survival in mice.
@en
type
label
Anti-complement component C5 m ...... ac allograft survival in mice.
@ast
Anti-complement component C5 m ...... ac allograft survival in mice.
@en
prefLabel
Anti-complement component C5 m ...... ac allograft survival in mice.
@ast
Anti-complement component C5 m ...... ac allograft survival in mice.
@en
P2093
P2860
P1476
Anti-complement component C5 m ...... iac allograft survival in mice
@en
P2093
M B Vieyra
P S Heeger
P Tamburini
P2860
P304
P356
10.1111/J.1600-6143.2011.03561.X
P407
P577
2011-06-10T00:00:00Z